Vitura Health Ltd (ASX: VIT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Vitura Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $56.44 million
P/E Ratio 11.77
Dividend Yield 13.70%
Shares Outstanding 575.87 million
Earnings per share 0.017
Dividend per share 0.01
Year To Date Return -67.84%
Earnings Yield 8.49%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Vitura Health Ltd (ASX: VIT)
    Latest News

    A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
    Cannabis Shares

    How did ASX cannabis shares perform in FY22?

    Here's a look at the sector's performance in the financial year just gone.

    Read more »

    A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
    Cannabis Shares

    Remember when ASX cannabis shares were smoking hot? Where are they now?

    Newly legalised recreational and medicinal marijuana markets aren't getting the media hype they once did.

    Read more »

    Young adult male farmer standing smiling in his indoor greenhouse full of herbal cannabis plants at a cannabis cultivation facility
    Cannabis Shares

    How have ASX cannabis shares been performing so far in 2022?

    The sector has held its own during volatile times.

    Read more »

    A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
    Cannabis Shares

    This little-known ASX cannabis share has quietly gained 26% in a month to trade at all-time highs

    Why is this ASX cannabis share having such a stellar month?

    Read more »

    Five healthcare workers standing together and smiling.
    Healthcare Shares

    2 ASX healthcare shares bucking the trend to hit new highs on Friday

    These healthcare shares are on form on Friday

    Read more »

    A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
    Share Gainers

    These were the best-performing ASX cannabis shares in 2021

    Despite a mixed bag for cannabis shares, some ended the year on a high

    Read more »

    a medical person in white coat, gloves and protective eyewear uses tools and a test tube to put cannabis buds into the tube for research purposes.
    Share Gainers

    Why is the Cronos (ASX:CAU) share price soaring 45% today?

    We check the latest on the ASX medical cannabis company.

    Read more »

    A white cannabis leaf set against a green background with a graph going up, indicating a rising share price for ASX cannabis shares
    Cannabis Shares

    What's the outlook for ASX Cannabis shares in 2022?

    December has been a tricky month for ASX cannabis shares.

    Read more »

    A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
    Cannabis Shares

    These were the top performing ASX cannabis shares in November

    It was a tough month for ASX cannabis shares but we've identified 3 diamonds in the rough.

    Read more »

    Falling cannabis asx share price represented by cannabis leaves on a declining line graph
    Share Market News

    What's going wrong for ASX cannabis shares lately?

    Why Aussie cannabis companies are worth watching right now...

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    04 Sep 2023 $0.0100 100.00% Final 28 Sep 2023
    16 Sep 2022 $0.0100 100.00% Final 11 Oct 2022

    VIT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Vitura Health Ltd

    Vitura Health Ltd is focused on creating medicinal cannabis products and digital health solutions that connect and strengthen the ecosystem between patients, prescribers, pharmacists, and suppliers. The company has two business segments namely, Sales and distribution (involving the sale and distribution of medical products including medicinal cannabis, psychedelic drugs, and smoking cessation products) and Clinics and services (involving the operation of medicinal cannabis clinics and the provision of related services). The company generates the majority of its revenue from the Sales and distribution segment. Geographically the company generates the majority of its revenue from Australia.

    VIT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    20 Nov 2024 $0.10 $0.00 0.00% 2,881 $0.10 $0.10 $0.10
    19 Nov 2024 $0.10 $0.00 0.00% 134,917 $0.09 $0.10 $0.09
    18 Nov 2024 $0.09 $0.00 0.00% 64,187 $0.10 $0.10 $0.09
    15 Nov 2024 $0.09 $0.00 0.00% 330,098 $0.10 $0.10 $0.09
    14 Nov 2024 $0.10 $0.00 0.00% 7,766 $0.10 $0.10 $0.10
    13 Nov 2024 $0.10 $0.00 0.00% 614,864 $0.10 $0.10 $0.10
    12 Nov 2024 $0.10 $0.00 0.00% 51,671 $0.10 $0.10 $0.10
    11 Nov 2024 $0.10 $0.00 0.00% 114,301 $0.10 $0.10 $0.10
    08 Nov 2024 $0.10 $0.00 0.00% 138,408 $0.10 $0.10 $0.10
    07 Nov 2024 $0.10 $0.00 0.00% 816,028 $0.10 $0.10 $0.10
    06 Nov 2024 $0.10 $0.00 0.00% 97,496 $0.10 $0.10 $0.10
    05 Nov 2024 $0.10 $0.00 0.00% 283,879 $0.10 $0.10 $0.10
    04 Nov 2024 $0.10 $0.00 0.00% 126,850 $0.10 $0.10 $0.10
    01 Nov 2024 $0.10 $-0.01 -9.52% 278,915 $0.11 $0.11 $0.10
    31 Oct 2024 $0.11 $0.00 0.00% 25,066 $0.11 $0.11 $0.10
    30 Oct 2024 $0.11 $0.00 0.00% 207,215 $0.11 $0.11 $0.11
    29 Oct 2024 $0.11 $0.01 10.53% 1,542,864 $0.10 $0.11 $0.10
    28 Oct 2024 $0.10 $0.01 11.11% 3,565,382 $0.09 $0.11 $0.09
    25 Oct 2024 $0.09 $0.00 0.00% 389,810 $0.10 $0.10 $0.09
    24 Oct 2024 $0.09 $-0.01 -10.00% 641,055 $0.11 $0.11 $0.09
    23 Oct 2024 $0.10 $0.00 0.00% 51,793 $0.10 $0.11 $0.10
    22 Oct 2024 $0.10 $-0.02 -17.39% 452,047 $0.11 $0.11 $0.10

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    04 Sep 2024 Robert Iervasi Buy 179,200 $15,076
    On-market trade.
    30 May 2024 Jenelle Frewen Buy 190,740 $25,944
    On-market trade.
    28 May 2024 Robert Iervasi Buy 280,250 $24,795
    On-market trade.
    29 Apr 2024 Guy Headley Sell 3,500,000 $385,000
    On-market trade.
    23 Apr 2024 Guy Headley Sell 10,000,000 $1,100,000
    On-market trade.
    15 Dec 2023 Rodney Cocks Issued 1,241,808 $335,288
    Issue of securities.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Guy Rothwell Headley Non-Executive Director Dec 2021
    Mr Headley has operated in the Australian Medical Cannabis space since 2016. He is a founding director of CDA Health Pty Ltd and has acted as a director of Burleigh Heads Cannabis Pty Ltd over the last eight years. He brings knowledge regarding medicinal cannabis sales, distribution and compliance in the heavily regulated industry. Prior to working in the cannabis space, Guy spent more than 15 years in the construction and development sector overseeing the procurement and management of multimillion dollar projects across New Zealand, Australia and the United Kingdom. Guy is also a founding Director and Chairman of the Emerging Therapeutics Association of Australia.
    Ms Marcia Ani Matekino Walker Non-Executive Director Dec 2021
    Dr Walker brings in Medical Governance and formerly served on the board of the New Zealand Medical Association and as a member of the General Practitioner Council of the NZMA, a member of the Medicines Classifications Committee for the Ministry of Health NZ and acts as a Medical Examiner for the Royal New Zealand College of General Practitioners. Previously, she acted as a Medical Advisor to the Rua BioScience (formerly Hikurangi Hemp Company) and as Treasurer for the New Zealand Resident Doctors Association. She is a Director and Treasurer of advocacy group General Practitioners Aotearoa and acts as the Medical Director of The Cosmetic Clinic New Zealand.
    Ms Jenelle Lee Frewen Non-Executive Director Sep 2022
    Mr Frewen is a government strategist and Cabinet-level adviser with more than two decades of experience spanning complex policy development and implementation in highly regulated industries. She has advised a range of business clients on strategic communications, public affairs and regulatory policy. Jenelle has experience working at all three levels of government in Australia and in new areas of policymaking in technology, broadband and cyber safety. Jenelle also spent time in her early career working as a communications and media adviser in the private sector.
    Mr Robert Iervasi Non-Executive ChairmanNon-Executive Director Feb 2024
    Mr Iervasi as the former Group CEO and Director of Asahi Beverages, Robert led a diversified consumer products / FMCG business with more than $5 billion in annual revenue and over 5,000 employees, including a manufacturing footprint. Prior to this, he served as the Group COO and CFO and General Counsel of Asahi for over eight years, managing Finance, Shared Business Services, Legal, Risk Strategy and Information Technology, as well Sales, Marketing, Supply Chain and Science and Innovation. Robert has successfully driven profitability and growth across multiple categories, brands and channels. In 2020, he identified and executed the acquisition by Asahi of Carlton & United Breweries. Robert brings experience and expertise in governance, finance, law, and innovation to Vitura.
    Mr Thomas Godfrey Howitt Chief Financial OfficerCompany SecretaryInterim CEO Aug 2020
    -
    Thomas Godfrey Howitt Chief Financial OfficerCompany SecretaryInterim CEO
    -
    Nicola M. Swarbrick Chief Operating Officer
    -
    Ryan Tattle Chief Revenue Officer
    -
    Stefan Schmidt Chief Technology Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Elizabeth Sarah Jansen <Stanford Investment Trust> 118,757,765 20.62%
    Guy Rothwell Headley 95,548,772 16.59%
    Cronos Global Holdings Inc. 55,176,065 9.58%
    Matua Hasyo Charlie Jansen <Whanau Family Trust> 44,117,428 7.66%
    NewSouthern Investment Holdings 1 Pty Ltd <NewSouthern Investment Trust 1> 21,000,000 3.65%
    NewSouthern Investment Holdings A Pty Ltd 18,441,007 3.20%
    Citicorp Nominees Pty Limited 13,225,910 2.31%
    HSBC Custody Nominees (Australia) Limited 11,284,879 1.96%
    Ashanna Pty Ltd 10,766,897 1.87%
    Melbourne Securities Corporation Limited <BV1 Fund A/C> 9,000,000 1.56%
    Stone Group Pty Ltd <Stone Children A/C> 6,377,765 1.11%
    UBS Nominees Pty Ltd 5,833,174 1.01%
    EJ Watson (Medical) Pty Ltd <The EJ Watson Med S/F A/C> 5,000,000 0.87%
    Jessimine Jansen 4,253,379 0.74%
    Hektares SG Holdings Pte Ltd 4,050,940 0.70%
    Daniel Francis Birch <BES A/C> 3,766,498 0.65%
    Craig Graeme Chapman <Nampac Discretionary A/C> 3,500,000 0.61%
    Ryan Tattle 3,451,189 0.60%
    Robert Charles Hussey 3,000,000 0.52%
    William David Copland and Susan Mary Copland David Copland Super fund A/C> 2,484,000 0.43%

    Profile

    since

    Note